SU1452484A3 - Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С - Google Patents

Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С Download PDF

Info

Publication number
SU1452484A3
SU1452484A3 SU853964395A SU3964395A SU1452484A3 SU 1452484 A3 SU1452484 A3 SU 1452484A3 SU 853964395 A SU853964395 A SU 853964395A SU 3964395 A SU3964395 A SU 3964395A SU 1452484 A3 SU1452484 A3 SU 1452484A3
Authority
SU
USSR - Soviet Union
Prior art keywords
acid
complex
production
strain
medium
Prior art date
Application number
SU853964395A
Other languages
English (en)
Russian (ru)
Inventor
Милтон Хабер Флойд
Льюис Пипер Ричард
Джозеф Титц Энтони
Эдвард Итон Том
Максин Форд Линда
Вебстер Годфри Отис (младший)
Льюис Браун Хабер Мери
Джозеф Цмиевски Милтон (Младший)
Original Assignee
Эли Лилли Энд Компани (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани (Фирма) filed Critical Эли Лилли Энд Компани (Фирма)
Application granted granted Critical
Publication of SU1452484A3 publication Critical patent/SU1452484A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
SU853964395A 1984-10-09 1985-10-08 Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С SU1452484A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65897984A 1984-10-09 1984-10-09

Publications (1)

Publication Number Publication Date
SU1452484A3 true SU1452484A3 (ru) 1989-01-15

Family

ID=24643546

Family Applications (1)

Application Number Title Priority Date Filing Date
SU853964395A SU1452484A3 (ru) 1984-10-09 1985-10-08 Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С

Country Status (27)

Country Link
EP (1) EP0178152B1 (enExample)
JP (1) JPH0787796B2 (enExample)
KR (1) KR890000800B1 (enExample)
CN (2) CN1013120B (enExample)
AT (1) ATE67788T1 (enExample)
AU (2) AU4837785A (enExample)
BG (1) BG47040A3 (enExample)
CS (2) CS276978B6 (enExample)
CY (1) CY1633A (enExample)
DD (2) DD238068A5 (enExample)
DE (1) DE3584218D1 (enExample)
DK (2) DK165416C (enExample)
EG (1) EG17619A (enExample)
ES (2) ES8700862A1 (enExample)
FI (1) FI82075C (enExample)
GR (1) GR852432B (enExample)
HK (1) HK24292A (enExample)
HU (1) HU196845B (enExample)
IE (1) IE58655B1 (enExample)
IL (1) IL76608A (enExample)
NZ (1) NZ213731A (enExample)
PH (1) PH21217A (enExample)
PL (1) PL152359B1 (enExample)
PT (1) PT81265B (enExample)
SG (1) SG3292G (enExample)
SU (1) SU1452484A3 (enExample)
ZA (1) ZA857759B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294990A3 (en) * 1987-06-10 1990-05-09 Eli Lilly And Company Chromatographic purification process
US4930494A (en) * 1988-03-09 1990-06-05 Olympus Optical Co., Ltd. Apparatus for bending an insertion section of an endoscope using a shape memory alloy
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6911525B2 (en) 1999-12-15 2005-06-28 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
RU2512396C2 (ru) 2008-12-22 2014-04-10 Кьюбист Фармасьютикалз, Инк. Новые противобактериальные средства для лечения грамположительных инфекций
BR112012012406B1 (pt) 2009-11-23 2021-11-16 Cubist Pharmaceuticals Llc Composições farmacêuticas sólidas de daptomicina, seu produto farmacêutico e seus métodos de fabricação
JP6336902B2 (ja) * 2011-06-22 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー．リミテッド コンジュゲートベースの抗真菌性および抗菌性プロドラッグ
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
CN107964557B (zh) * 2018-01-17 2020-11-20 自然资源部第三海洋研究所 一种提高芽孢杆菌抗菌脂肽产量的发酵方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент US № 4331594, кл. 260-112.5, 1984. Патент US № 4537717, кл. 260-112.5, 1986. *

Also Published As

Publication number Publication date
IL76608A0 (en) 1986-02-28
HU196845B (en) 1989-01-30
AU4837785A (en) 1986-04-17
JPH0787796B2 (ja) 1995-09-27
EP0178152A3 (en) 1988-11-02
DK165757B (da) 1993-01-11
DK457585A (da) 1986-04-10
HUT39782A (en) 1986-10-29
FI82075C (fi) 1991-01-10
ES547689A0 (es) 1986-11-16
IE852466L (en) 1986-04-09
DK165416C (da) 1993-04-05
FI853910L (fi) 1986-04-10
DD247023A5 (de) 1987-06-24
PT81265A (en) 1985-11-01
CN1013120B (zh) 1991-07-10
CS276978B6 (en) 1992-11-18
AU5375290A (en) 1990-11-01
KR890000800B1 (ko) 1989-04-07
JPS6192588A (ja) 1986-05-10
BG47040A3 (en) 1990-04-16
DK148791D0 (da) 1991-08-21
NZ213731A (en) 1988-04-29
EP0178152B1 (en) 1991-09-25
FI853910A0 (fi) 1985-10-08
PL255683A1 (en) 1986-07-29
ES553603A0 (es) 1987-11-01
CS276983B6 (en) 1992-11-18
DD238068A5 (de) 1986-08-06
PT81265B (pt) 1988-02-17
EP0178152A2 (en) 1986-04-16
KR860003335A (ko) 1986-05-23
ES8700862A1 (es) 1986-11-16
SG3292G (en) 1992-03-20
PL152359B1 (en) 1990-12-31
DK165757C (da) 1993-06-07
FI82075B (fi) 1990-09-28
GR852432B (enExample) 1986-02-10
DE3584218D1 (de) 1991-10-31
DK148791A (da) 1991-08-21
PH21217A (en) 1987-08-21
CN85107552A (zh) 1987-05-20
DK457585D0 (da) 1985-10-08
ATE67788T1 (de) 1991-10-15
EG17619A (en) 1991-03-30
IE58655B1 (en) 1993-11-03
DK165416B (da) 1992-11-23
HK24292A (en) 1992-04-10
CY1633A (en) 1992-11-06
CN1051200A (zh) 1991-05-08
ES8800362A1 (es) 1987-11-01
ZA857759B (en) 1987-05-27
CS819286A3 (en) 1992-03-18
IL76608A (en) 1991-03-10
CS719885A3 (en) 1992-03-18
AU634766B2 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
SU1452484A3 (ru) Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С
EP0046284B1 (en) Method for preparing 2,5-diketo-d-gluconic acid and microorganisms for carrying out the method
NO150785B (no) Fremgangsmaate for fremstilling av toerre stivelseholdige naeringsmidler
US4800157A (en) Process for producing the A-21978C antibiotics
EP0379395A2 (en) Antibiotic L53-18A and process for preparation thereof
JPH02124883A (ja) 抗酸化作用を有するイソフラボン誘導体およびその製造法
HU196220B (en) Process for preparing novel antrocycline derivatives
IE50834B1 (en) Preparation of 2-keto-l-gulonic acid
US4064013A (en) Process for preparing thiostrepton
SU539538A3 (ru) Способ получени метаболита "а 27 106
JPH0329079B2 (enExample)
SU1431682A3 (ru) Способ получени антибиотика СР-63517,используемого в качестве кормовой добавки дл крупного рогатого скота и свиней
US4628046A (en) Antibiotic LL-C23201δ
NO135182B (enExample)
IE51169B1 (en) Process for preparing polyether antibiotic
RU2043416C1 (ru) Способ получения тилозина
KR890002698B1 (ko) 헤테로 폴리사카라이드 s-184 및 이의 제조방법
US3433710A (en) Process for the preparation of 7-chloro-5-hydroxytetracycline
US2996435A (en) Process for producing azaserine
US5234819A (en) Method for preparing 2,5-diketo-D-gluconic acid
Ohno et al. Improvement of the productivity of elasnin, a specific elastase inhibitor, by Streptomyces noboritoensis KM-2753
CA1274795A (en) Process for producing the a-21978c antibiotics
JPS6331477B2 (enExample)
US3734832A (en) Fermentation process for producing physostigmine
KR0154492B1 (ko) 신규 항생물질 엠알-93에이 및 이의 제조방법